Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Caiwen Du"'
Autor:
Qiao Li, Ying Cheng, Zhongsheng Tong, Yunjiang Liu, Xian Wang, Min Yan, Jianhua Chang, Shusen Wang, Caiwen Du, Liang Li, Chunjiao Wu, Mingxia Wang, Zhuo Wang, Zhuli Wu, Xingli Wang, Yongli Jin, Lei Diao, Yi Sun, Yongjiao Zhang, Ai-Min Hui, Binghe Xu
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-10 (2024)
Abstract Currently approved HER2-targeting antibody-drug conjugates (ADCs) for HER2-positive breast cancer (BC) are associated with safety concerns. In this multicenter, single-arm, dose-escalation (phase 1a) and dose-expansion (phase 1b) phase 1 tri
Externí odkaz:
https://doaj.org/article/a970daa7143b4f0c9d62cb86b63129d8
Autor:
Dongshao Chen, Fei Xu, Yongkui Lu, Wen Xia, Caiwen Du, Dun Xiong, Dong Song, Yanxia Shi, Zhongyu Yuan, Qiufan Zheng, Kuikui Jiang, Xin An, Cong Xue, Jiajia Huang, Xiwen Bi, Meiting Chen, Jingmin Zhang, Shusen Wang, Ruoxi Hong
Publikováno v:
npj Breast Cancer, Vol 10, Iss 1, Pp 1-7 (2024)
Abstract Human epidermal growth factor receptor 2-positive (HER2+) breast cancer (BC) patients are at a high risk of developing metastases in the brain. However, research focusing on treatment strategies for hormonal receptor positive (HR+), HER2+ BC
Externí odkaz:
https://doaj.org/article/074a02d6944e425fbc909d21f71d3bfc
Autor:
Yuxuan Gao, Mengmeng Zhang, Gang Sun, Li Ma, Jianyun Nie, Zhongyu Yuan, Zhenzhen Liu, Yali Cao, Jianbin Li, Qiang Liu, Songqing Ye, Bo Chen, Yuhua Song, Kun Wang, Yu Ren, Guolin Ye, Ling Xu, Shu Liu, Qianjun Chen, Weiwen Li, Xinxin Chen, Peifen Fu, Wei Wei, Baoliang Guo, Hebing Wang, Zhenhai Cai, Caiwen Du, Zhiyong Wu, Xiaoming Zha, Heng Huang, Juan Xu, Chenglei Zhang, Yingying Shi, Ting Liu, Sihua Liu, Zefei Jiang, Ying Lin
Publikováno v:
Breast, Vol 76, Iss , Pp 103762- (2024)
Background: Male breast cancer (MBC) is a rare disease. Although several large-scale studies have investigated MBC patients in other countries, the features of MBC patients in China have not been fully explored. This study aims to explore the feature
Externí odkaz:
https://doaj.org/article/6ea2938e673a4a80ae96bab2b536adae
Autor:
Qiuyi Zhang MD, Xiaofeng Lan MD, Jiayi Huang MD, Xiaofeng Xie MD, Liping Chen MD, Lin Song MD, Xue Bai MD, Xuelian Chen PhD, Haiman Jing PhD, Caiwen Du PhD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 23 (2024)
Objective This real-world study aimed to investigate the efficacy and safety of palbociclib plus endocrine therapy in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer in the real world
Externí odkaz:
https://doaj.org/article/75c5365ae965468a8685b9517cecd169
Autor:
Xuelian Chen, Xue Bai, Xiaofeng Xie, Jiayi Huang, Liping Chen, Lin Song, Xiaofeng Lan, Qiuyi Zhang, Jinfeng Guo, Caiwen Du
Publikováno v:
Annals of Medicine, Vol 55, Iss 1 (2023)
AbstractBackground More than half of the metastatic breast cancer patients with brain metastases (BCBM) are HER-2 negative, and the prognosis of HER2-negative BCBM is dismal. But few clinical trials have investigated systemic therapies for this subgr
Externí odkaz:
https://doaj.org/article/ac220bf5ba154006999d8734e54a7012
Autor:
Fei Ma, Xinlan Liu, Yanxia Shi, Xiuwen Guan, Huihui Li, Xiaojia Wang, Yuee Teng, Qiang Liu, Jin Yang, Man Li, Qingyuan Zhang, Weihong Zhao, Caiwen Du, Lili Sheng, Binghe Xu
Publikováno v:
Cancer Research. 82:P1-16
Background: Metronomic chemotherapy, defined as frequent administration of. chemotherapeutic agents at a non-toxic dose without extended rest periods, can overcome drug resistance and achieve disease control with reduced toxicity compared to conventi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d2299be861a2ca6b8deca842680ff026
https://doi.org/10.1158/1538-7445.sabcs21-p1-16-02
https://doi.org/10.1158/1538-7445.sabcs21-p1-16-02
Autor:
Jiayi Huang, Xue Bai, Xiaofeng Xie, Liping Chen, Xiaofeng Lan, Qiuyi Zhang, Lin Song, Pengjiao Hong, Caiwen Du
Publikováno v:
Oncologie. 24:131-145
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3165b8144fa4facc9f8a897d7182442a
https://doi.org/10.32604/oncologie.2022.019881
https://doi.org/10.32604/oncologie.2022.019881
Publikováno v:
Oncology Letters. 25
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::60718f0ad73017c5f73fcea9fbe19d5d
https://doi.org/10.3892/ol.2022.13642
https://doi.org/10.3892/ol.2022.13642
Autor:
Sixian Liang, Xun Peng, Xiaoli Li, Ping Yang, Linhao Xie, Yaochen Li, Caiwen Du, Guojun Zhang
Publikováno v:
Oncotarget. 13:583-584
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a37de0daee639e4e26e9d1716fad0f0
https://doi.org/10.18632/oncotarget.28109
https://doi.org/10.18632/oncotarget.28109
Autor:
Shanshan Zhuang, Songmin Ying, Min Su, Guoqiang Zhang, Min Zhang, Juan Ji, Jiaxuan Zheng, Su Xue, Yuping Chen, Chong Zhang, Zexin Xu, Yi Guo, Huan Yu, Ruijing Yan, Guo-Hong Zhang, Runhua Lin, Caiwen Du, Shaobin Chen, Songnian Hu, Yuan Wang, Dongping Tian, Jiancheng Cui, Moshe Marom, Yuanning Guo, Li Ruiqiang, Qi Zheng, Sitong Sheng, Wanting Deng, Xi Liu, Xiang Li, Shiyue Qiu
Publikováno v:
Gastroenterology. 153(1)
Background & Aims Esophageal squamous cell carcinoma (ESCC) is the most common subtype of esophageal cancer. Little is known about the genetic changes that occur in esophageal cells during the development of ESCC. We performed next-generation sequenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f589974d3a7d137deba172acd8e2f9fc
https://pubmed.ncbi.nlm.nih.gov/28365443
https://pubmed.ncbi.nlm.nih.gov/28365443